Clinical trial
Chemotherapy With Whole Body Hyperthermia to Treat Resistant Breast…
NCT00178802 · The University of Texas Health Science Center, Houston, Other · Unknown status
Key facts
| NCT number | NCT00178802 |
|---|---|
| Title | Chemotherapy With Whole Body Hyperthermia to Treat Resistant Breast, Endometrial, Cervical and Ovarian Cancers |
| Official title | Phase II Study of Mild Whole Body Hyperthermia Combined With 5-Fluorouracil/Interferon-a/Liposomal Doxorubicin in Patients With Advanced Malignancy |
| Lead sponsor | The University of Texas Health Science Center, Houston, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Neoplasms, Endometrial Neoplasms, Cervix Neoplasms, Ovarian Neoplasms |
| Intervention type | Other |
| Interventions | thermochemotherapy (with 5-fluorouracil/interferon-a/liposomal doxorubicin) |
| Enrollment | 24 |
| Start date | Jun 1, 1996 |
| Primary completion | Jun 1, 2010 |
| Completion | Dec 1, 2010 |
| First posted | Sep 15, 2005 |
| Last update posted | Apr 23, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: